Literature DB >> 24128898

Technetium-99m methoxyisobutylisonitrile scintigraphy in the assessment of cold thyroid nodules: is it time to change the approach to the management of cold thyroid nodules?

Ahmad Riazi1, Mohammadreza Kalantarhormozi, Iraj Nabipour, Seyed S Eghbali, Mohammadreza Farzaneh, Hamid Javadi, Afshin Ostovar, Mohammad Seyedabadi, Majid Assadi.   

Abstract

BACKGROUND: Scanning with technetium-99m methoxyisobutylisonitrile (Tc-MIBI) is recommended for evaluating thyroid nodule metabolism. In addition, it may help differentiate between benign and malignant nodules; however, the efficacy of this technique has not been fully elucidated. Therefore, it is not currently performed for routine clinical application. This prospective study was conducted to investigate the clinical significance of Tc-MIBI scintigraphy in the assessment of patients with cold thyroid nodules. PATIENTS AND METHODS: This prospective study was conducted on 104 patients with cold thyroid nodules greater than 1 cm in diameter as detected on Tc-pertechnetate scintigraphy. Uptake of MIBI in thyroid nodules was compared with that in the surrounding normal thyroid tissue for both early and delayed images, and a score of 0-3 was assigned to each nodule as follows: 0, cold; 1, decreased; 2, equal; 3, increased. The thyroid scan was performed 20 and 40 min after intravenous injection of 555 MBq of Tc-MIBI. The patients underwent fine-needle aspiration cytology (FNAC). Detailed statistical parameters were determined on a per-nodule basis for each qualitative and quantitative scan analysis, as defined by histology.
RESULTS: A total of 104 patients (93 women and 11 men; mean age 40.76±11.40 years, range 20-73) with a total number of 167 cold nodules were included in this study. When Tc-MIBI uptake was regarded as the criterion of malignancy in Tc-MIBI scintigraphy, the accuracy was between 69.46 and 92.21% on using seven different methods. In addition, FNAC findings indicated a sensitivity of 66.66%, a specificity of 100%, a negative predictive value of 95.72%, a positive predictive value of 100%, and an accuracy of 96.06%. Six malignant cold nodules were detected on a positive Tc-MIBI scan, which were determined as benign nodules on FNAC examinations.
CONCLUSION: The study demonstrated that Tc-MIBI scanning can be complementary to other diagnostic techniques in patients with cold thyroid nodules. In addition, because of its availability, rather low cost, simple protocol, and objective semiquantitative information, Tc-MIBI scanning seems to hold promise in routine imaging of cold thyroid nodules.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24128898     DOI: 10.1097/MNM.0000000000000013

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  10 in total

1.  Comments on Wale et al. : Combined (99)mTc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.

Authors:  Ahmad Riazi; Mohammadreza Kalantarhormozi; Iraj Nabipour; Afshin Ostovar; Hamid Javadi; Majid Assadi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-18       Impact factor: 9.236

2.  Increasing Importance.

Authors:  Tim Scholz
Journal:  Dtsch Arztebl Int       Date:  2017-01-09       Impact factor: 5.594

3.  Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidism.

Authors:  Tristan Greilsamer; Claire Blanchard; Niki Christou; Delphine Drui; Catherine Ansquer; Maelle Le Bras; Bertrand Cariou; Cécile Caillard; Emmanuelle Mourrain-Langlois; Anne Sophie Delemazure; Muriel Mathonnet; Françoise Kraeber-Bodéré; Eric Mirallié
Journal:  Langenbecks Arch Surg       Date:  2015-02-20       Impact factor: 3.445

4.  Systematic review and meta-analysis of the diagnostic value of radionuclide imaging for thyroid nodules.

Authors:  Xin Song; Zhongmei Luo; Haiyan Sun; Lingna Hao
Journal:  Gland Surg       Date:  2021-12

5.  Diagnostic Performance of 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study.

Authors:  Simone Agnes Schenke; Alfredo Campennì; Murat Tuncel; Gianluca Bottoni; Sait Sager; Tatjana Bogovic Crncic; Damir Rozic; Rainer Görges; Pinar Pelin Özcan; Daniel Groener; Hubertus Hautzel; Rigobert Klett; Michael Christoph Kreissl; Luca Giovanella
Journal:  Diagnostics (Basel)       Date:  2022-05-31

6.  Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?

Authors:  Luis Mauricio Hurtado-López; Fernando Fernández-Ramírez; Eva Martínez-Peñafiel; José Damián Carrillo Ruiz; Norma Estela Herrera González
Journal:  Med Sci Monit       Date:  2015-06-16

7.  Early assessment of high-intensity focused ultrasound treatment of benign thyroid nodules by scintigraphic means.

Authors:  Huedayi Korkusuz; Niklas Fehre; Michael Sennert; Christian Happel; Frank Grünwald
Journal:  J Ther Ultrasound       Date:  2014-09-30

8.  Values of (99m)Tc-methoxyisobutylisonitrile imaging after first-time large-dose (131)I therapy in treating differentiated thyroid cancer.

Authors:  Xiaomei Pan; Dong Duan; Yuquan Zhu; Hua Pang; Lili Guan; Zhixiang Lv
Journal:  Onco Targets Ther       Date:  2016-02-10       Impact factor: 4.147

9.  Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy.

Authors:  A Campennì; M Siracusa; R M Ruggeri; R Laudicella; S A Pignata; S Baldari; L Giovanella
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

10.  99mTc-MIBI Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study.

Authors:  Mehrzad Bahtouee; Jamshid Saberifard; Hamid Javadi; Iraj Nabipour; Alireza Raeisi; Majid Assadi; Mohammad Eftekhari
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.